top of page
Ectembly-logo-2022-dark-text_RGB_72dpi_v2.png
Ectembly-logo-2022-dark-text_RGB_72dpi_v2.png

Etcembly's T-cell engager featured in Inside Precision Medicine

  • Writer: David Tokley
    David Tokley
  • Aug 23, 2023
  • 1 min read

The announcment of Etcembly's picomolar affinity bispecific T-cell engager targeting PRAME, ETC-101, has been covered by inside Precision Medicine - Generative AI Used to Develop T Cell Cancer Immunotherapy 





 
 
 

Kommentare

bottom of page